2016 Innovation Grants - Professor Des Richardson

New therapeutic tools
Professor Des Richardson Panel Image

Professor Des Richardson

Grant

Development of Novel Agents that Target P-Glycoprotein Resistant Pancreatic Cancer

Award

2015 Innovation Grant

Institution

University of Sydney

Drug resistance is a major factor underlying the limited response of pancreatic cancer to chemotherapy. The project team’s drug design strategy is to target resistant pancreatic cancer by taking advantage of detoxifying P-glycoprotein pump to transport our drugs DIRECTLY to their sensitive site of action in the cancer cell (namely, the LYSOSOME).

Professor Des Richardson Panel Image

Professor Des Richardson

Progress Report